Wednesday, January 13, 2021 8:58:12 AM
EVGN showing solid strength, we should see a run to $6+ soon. then $10+ small float & owned by ARKG Cathie Wood
January 11th 2021 Global Agricultural Biotechnology Market Outlook 2020,Business Overview by 2027 Available in Latest Report Biomica, Evogene Ltd., Canonic ltd. , Bayer AG, Valent BioSciences LLC
The agricultural biotechnology business is anticipated to augment business germination in the projection period of 2020 to 2027 reckoning to USD 74.55 billion by 2027 expanding at an annual growth of 9.94% in the above-mentioned projection years.
This agricultural biotechnology market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on agricultural biotechnology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Download Sample PDF Copy of Report https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-agricultural-biotechnology-market
The major players covered in the agricultural biotechnology market report are KWS SAAT SE & Co. KGaA, ChemChina, Corteva., Limagrain, MITSUI & CO., LTD., AgPlenus ltd., Biomica, Evogene Ltd., Canonic ltd., Bayer AG, Valent BioSciences LLC, Nufarm Limited, Marrone Bio Innovations., Performance Plants Inc., ADAMA Ltd. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Focusing points in the report
Key trends in the market place
Major players and brands
Drivers and restrains of the market
Strategies of key players and product offerings
In-depth market segmentation
Global Agricultural Biotechnology Market Scope and Market Size
Agricultural biotechnology market is segmented on the basis of type, application, organism type, technology, and product. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
On the basis of type, agricultural biotechnology market is segmented into molecular diagnostics, molecular markers, tissue culture, vaccines, genetic engineering, and others.
On the basis of application, the agricultural biotechnology market is bifurcated into transgenic crops, flower culturing, nutritional supplements, biofuels, antibiotic development, vaccine development and others.
On the basis of organism type, the agricultural biotechnology market is divided into plants, animals, microbes, and others.
On the basis of technology, the agricultural biotechnology market is fragmented into genome editing tools, ribonucleic acid interference [RNAi], biochips, deoxy ribonucleic acid [DNA] sequencing, and synthetic biology.
Based on the product, the agricultural biotechnology market is segregated into crop protection products, transgenic seeds, and synthetic biology-enables products. Crop protection products are further sub-categorized into biostimulants, and biopesticides. Transgenic seeds are further sub-segmented into soybean, fruits & vegetables, maize, cotton, and others.
Inquiry For Customize Report With Discount At https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-agricultural-biotechnology-market
Drivers:Global Agricultural Biotechnology Market
Escalated penetration of biotechnology, tissue culture, and molecular breeding and unique plant breeding is defining the success parameters of agricultural biotechnology market.
Agricultural biotechnology market is flourishing exponentially owing to the advancement of agriculture sciences this factor is driving the market growth.
Increment in the production and breeding of transgenic crop because of rising food demand from the consumer end is helping the agricultural biotechnology market to grow. Implementation of biotechnology tools to enhance the production value in terms of size, color, or yield of crops by modifying their traits is catering a potential market base for agricultural biotechnology business.
Adoption of biofuels and quality food demand which is free from pesticides or insecticides constituents is helping the agricultural biotechnology market a good volume of revenue and stock shares, in the developed and emerging pockets of farming countries. These certain values are driving the market growth of agricultural biotechnology market in the anticipated time phase of 2020 to 2027.
During the seven years period of business, agricultural biotechnology market is exposed to face some restraints and curbing factors such as dearth of adoption of such products by consumer base due to scarcity of knowledge, stringent regulations by government for modified crops. These parameters may impact the market growth. The upcoming technological advancements centrally focused upon producing quality crops and widening penetration of biotech-crop tactics in agriculture industry will help in to overcome the mentioned challenges.
Important Points Covered in Agricultural Biotechnology Market Report Are:
Study Coverage
Executive Summary
Breakdown Data by Manufacturers
Breakdown Data by Product
Breakdown Data by End User
Breakdown Data by Countries
Agricultural Biotechnology Market Opportunities, Challenges, Risks and Influences Factors Analysis
Company Profiles
Future Forecast (2020-2027)
Value Chain and Sales Channels Analysis
Research Findings and Conclusion
And More.
To know more about the studyhttps://www.databridgemarketresearch.com/reports/global-agricultural-biotechnology-market
Customization Available: Global Agricultural Biotechnology Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com
https://ksusentinel.com/2021/01/11/global-agricultural-biotechnology-market-outlook-2020business-overview-by-2027-available-in-latest-reportbiomica-evogene-ltd-canonic-ltd-bayer-ag-valent-biosciences-llc/
EVGN Subsidiaries:
Evogene group supports independent entities focusing on a defined commercial field with an exclusive license to use our unique solution for product development.
1.Biomica
https://www.biomicamed.com/
2.Canonic
https://canonicbio.com/
3.AgPlenus
https://www.agplenus.com/
4.Lavie Bio
https://www.lavie-bio.com/
5.Castera
https://www.evogene.com/wp-content/uploads/2019/05/Casterra-company-presentation-ICOA-_pdf-version.pdf
Genome Stocks-Gene Editing.
$PACB 6.2 billion market cap
$BEAM 5.4 billion market cap
$EDIT 4.8 billion market cap
$SGMO 2.3 billion market cap
$NTLA 4.8 billion market cap
$BLUE 3.3 billion market cap
$BNGO 1.2 billion market cap
$EVGN 195 million market cap 35 million shares 45% owned by institutions & insiders
https://www.evogene.com/
$EVGN
Recent EVGN News
- Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting • PR Newswire (US) • 04/16/2024 11:00:00 AM
- Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting • PR Newswire (US) • 04/11/2024 11:00:00 AM
- Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry • PR Newswire (US) • 04/02/2024 11:00:00 AM
- Evogene Announces Filing of Annual Report on Form 20-F • PR Newswire (US) • 03/28/2024 01:00:00 PM
- Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification • PR Newswire (US) • 03/20/2024 01:00:00 PM
- Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing • PR Newswire (US) • 03/19/2024 01:00:00 PM
- Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America • PR Newswire (US) • 03/13/2024 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/07/2024 12:00:17 PM
- Evogene Reports Fourth Quarter and Full Year 2023 Financial Results • PR Newswire (US) • 03/07/2024 12:00:00 PM
- AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides • PR Newswire (US) • 03/06/2024 12:00:00 PM
- Casterra Announces New Agreements with Seed Producers in Brazil and Africa to Meet Growing Demand for its Elite Castor Seed Varieties • PR Newswire (US) • 03/05/2024 12:00:00 PM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 03/01/2024 12:03:59 PM
- Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements • PR Newswire (US) • 02/28/2024 12:00:00 PM
- Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024 • PR Newswire (US) • 02/26/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/22/2024 12:00:08 PM
- AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer • PR Newswire (US) • 02/22/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/21/2024 12:01:13 PM
- AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution • PR Newswire (US) • 02/21/2024 12:00:00 PM
- Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide • PR Newswire (US) • 02/20/2024 12:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/15/2024 01:30:01 AM
- Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation • PR Newswire (US) • 02/06/2024 12:08:00 PM
- Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit • PR Newswire (US) • 01/23/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/17/2024 12:00:06 PM
- Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug • PR Newswire (US) • 01/17/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/09/2024 01:30:57 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM